Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421065 | SCV000530604 | likely benign | not specified | 2016-08-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000726726 | SCV000702451 | uncertain significance | not provided | 2016-11-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083326 | SCV001009923 | likely benign | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828431 | SCV002091851 | likely benign | Leber congenital amaurosis | 2020-03-10 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004533083 | SCV004739347 | likely benign | CEP290-related disorder | 2020-01-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |